GlassScriptPhysician profile
Richard Heuser
NPI 1962493338
$68,434.05
in general payments reported to CMS, 2019-2025
45 companies · $17.57 in 2025
The $17.57 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $2,066 · 2021: $1,243 · 2022: $4,332 · 2023: $1,426 · 2024: $173 · 2025: $17.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.76 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $54,365.77 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Siemens Medical Solutions USA, INC. | $3,815.55 | 2021-2022 | |
| Penumbra, INC. | $2,051.93 | 2019 | |
| Amgen INC. | $1,841.35 | 2019-2023 | Repatha |
| Microvention, INC. | $1,250.00 | 2020 | |
| Medtronic Vascular, INC. | $853.08 | 2019-2020 | |
| Medtronic, INC. | $692.21 | 2021-2024 | Abre, Turbohawk, In.Pact Admiral |
| Abbott Laboratories | $585.68 | 2019-2025 | Mitraclip, Esprit |
| Provisio Medical, INC. | $500.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $383.55 | 2019-2024 | |
| Angiodynamics, INC. | $262.22 | 2020-2023 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $196.93 | 2019-2023 | |
| Cardiovascular Systems INC. | $173.93 | 2019 | |
| Surmodics, INC. | $154.82 | 2022-2023 | Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $139.24 | 2021-2023 | Xarelto |
Show all 44 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Heuser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.